Results from a clinical trial demonstrate that high doses of an experimental H5N1 avian influenza vaccine can induce immune responses in healthy adults
By: National Institute of Allergy and Infectious Diseases.
Contributors: National Institute of Allergy and Infectious Diseases (U.S.); National Institutes of Health (U.S.)
Series: NIH news
Publisher: National Institutes of Health
Published: 2006
Place of publication: [Washington, D.C.?]
Language: eng
Format: Electronic resource
Subjects: Influenza vaccines.; Avian influenza.
Notes: "EMBARGOED FOR RELEASE: Wednesday, March 29, 2006; 5:00 p.m. ET".

Contributed by FDLP Library Partner as part of the EPA Demonstration Project.

News and Events  Aging Initiative  EPA00274156.htm